Indefinite Delivery Contract 75F40118D10032
Award Date
9/27/18
Last Date to Order
9/26/23
Federal Agency
Food and Drug Administration
Awardee
Iqvia Government Solutions Inc.
Ultimate Awardee
Not listed
NAICS Category
518210 - Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) has awarded a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract, valued at up to $75,000,000.00, to Iqvia Government Solutions Inc. for the Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). This contract aims to obtain large-scale, longitudinal healthcare data from the United States covering tens of millions of...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides,...
The Department of Health and Human Services Food and Drug Administration awarded multiple indefinite delivery contracts under the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ. Iqvia Government Solutions Inc. received two delivery orders totaling $20 million to provide data sources and products/services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY INITIATIVE #3 effort. Performance will take place in Mosby, Virginia over periods from September 2020 through...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA)'s Center for Biologics Evaluation and Research (CBER) to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract, valued up to $75 million, supports the BEST Initiative #3 to obtain new data sources, including administrative claims data or claims and electronic health record (EHR) data, for post-market surveillance of biological drugs. The contractor must provide...
The contract IDV award from the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. is for access to over-the-counter (OTC) drug utilization data to strengthen the agency's Drug Utilization Program. Iqvia, a leading provider of healthcare data and analytics, will serve as the prime contractor to deliver aggregated and de-identified OTC drug transaction and demographic data to support the FDA's regulatory and research efforts overseeing non-prescription medications used by...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances.
Two task orders have been issued under this IDC. The...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract under the BEST (Biologics Effectiveness and Safety) Initiative to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract, with a $50 million ceiling value and performance period through September 2025, is for the procurement of data sources to support the FDA's surveillance of biologics.
Two task orders have been awarded to date under...
The Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has awarded an Indefinite Delivery Contract (IDC) valued at up to $75 million to Acumen LLC, doing business as Medric, to support the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3). The contract will provide CBER with access to large-scale, longitudinal healthcare data covering tens of millions of patients, including both administrative...